(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. Nkx2.2-derivative transgenes are expressed in patterns similar to
endogenous Nkx2.2 when expressed under the control of the Pdx1 promoter.
(A) Nkx2.2hdVP16 mRNA is expressed throughout the pancreatic
epithelium at E10.5 (L7319), E12.5 (L7318) and E15.5 (L7318), and is
restricted to endocrine cells at E18.5 (L7319). (B)
Nkx2.2hdEnR mRNA is detected in the pancreatic epithelium at E10.5,
E12.5 and E15.5, and strong expression is detected in the endocrine tissue at
E18.5 (all L7414). Both transgenes are expressed in a manner similar to
Nkx2.2 throughout development; however, a small amount of transgene
expression is detectable in acinar cells. (C) Real-time PCR
quantification of Nkx2.2-repressor and Nkx2.2-activator transgene expression
compared to endogenous Nkx2.2 expression. Percentages indicate percent
transgene expression relative to endogenous Nkx2.2. Nkx2.2hdVP16: line 7319
(n=5), line 7318 (n=4); Nkx2.2hdEnR: line 7414
(n=4), line 7660 (n=3).